REFERENCES
- Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–2651.
- Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Opthalmol. 2009;24:178–184.
- Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610–614.
- Denoyelle F, Leboulanger N, Enjolras O, Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73:1168–1172.
- Zaher H, Rasheed H, Hegazy RA, Oral propranolol: an effective, safe treatment for infantile hemangiomas. Eur J Dermatol. 2011;21:558–563.
- Chai Q, Chen WL, Huang ZQ, Preliminary experiences in treating infantile hemangioma with propranolol. Ann Plast Surg. 2011; May 27. (Epub ahead of publication)
- Erbay A, Sarialioglu F, Malbora B, Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr. 2010;52:450–456.
- Bagazgoitia L, Torrelo A, Guiterrez JC, Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28:108–114.
- Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456–1463.
- Payarols JP, Masferrer JP, Bellvert CG. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med. 1995;333:69.
- Hurvitz SA, Hurvitz CH, Sloninsky L, Sanford MC. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol. 2000;22:527–532.
- D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem. 1997;67:353–366.
- Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38:298–304.
- Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359:2846.
- Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics. 2010;126:e1589–e1593.
- Leboulanger N, Fayoux P, Teissier N, Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol. 2010;74:1254–1257.
- Fuchsmann C, Quintal MC, Giguere C, Propranolol as first line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg. 2011;137:471–478.